Trials.ai offers a Smart Protocol Solution — AI-enabled software that guides research teams through development of clinical trial protocols. The company positions its product as a way to reduce poorly designed protocols that cause trial failures and wasted R&D spend. Trials.ai says it already has commercial traction and aims to accelerate deployment of its software to get treatments to patients faster. CEO Kim Walpole is noted as an experienced startup leader who has attracted strong staff and advisors. The company is based in San Diego and highlights clinical trials as a segment ripe for AI-driven optimization. Financially, Trials.ai completed an oversubscribed funding round to support its deployment plans.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2019